NPPA issued a notification regarding the fixation of the retail price of Bisoprolol Fumarate I.P. 5 mg + Telmisartan I.P. 40 mg for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s Cadila Pharmaceuticals Ltd (Marketer)

Feb 11, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 10, 2025, issued a notification regarding the fixation of the retail price of Bisoprolol Fumarate I.P. 5 mg + Telmisartan I.P. 40 mg for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s Cadila Pharmaceuticals Ltd (Marketer).

The following has been stated: -

•Each film-coated tablet contains: Bisoprolol Fumarate I.P. 5 mg + Telmisartan I.P. 40 mg for M/s Ravenbhel Healthcare Pvt. Ltd. (Manufacturer) & M/s Cadila Pharmaceuticals Ltd (Marketer) the retail price is 11.92 (Rs).

[Notification No. 19(4424)/2025/DP/NPPA/DIV.III/9927/2025]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT